Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 20, Issue 8, 2013, Pages 550-555

  Younossi, Z M ^a,b   Stepanova, M ^a,b   Afendy, M ^a   Lam, B P ^b   Mishra, A ^b  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

HCV; knowledge; treatment predictors

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH STATUS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE;

HCV; KNOWLEDGE; TREATMENT PREDICTORS;

ADULT; AGED; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; UNITED STATES;

EID: 84879793520     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12080     Document Type: Article

References (32)

1. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW,. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138 (2): 513-521, 521
2. Bialek SR, Terrault NA,. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006; 10: 697-715.
3. Tan J, Lok AS,. Update on viral hepatitis: 2006. Curr Opin Gastroenterol 2007; 23 (3): 263-267.
4. McHutchison JG, Bacon BR,. Chronic hepatitis C: an age wave of disease burden. Am J Manag Care 2005; 11: S286-295; quiz S307-11
5. Leigh JP, Bowlus CL, Leistikow BN,. Costs of hepatitis C. Arch Intern Med 2001; 161: 2231-2237.
6. Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi V,. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011; 45 (2): e17-24.
7. Chung RT, Anderson J, Volberding P, et al,. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351: 451-459.
8. Buti M, Esteban R. 1990-2010: Two decades of inteferon-based therapy,. Clin Liver Dis 2011; 15: 473-482.
9. Ilyas J, Vierlin J,. An overview of emerging therapies for treatment of chronic hepatitis C. Clin Liver Dis 2011; 15: 515-536.
10. Jacobson IM, McHutchison JG, Dusheiko G, et al,. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364 (25): 2405-2416.
11. Zeuzem S, Andreone P, Pol S, et al,. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364 (25): 2417-2428.
12. Sherman KE, Flamm SL, Afdhal NH, et al,. ILLUMINATE Study Team. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med 2011; 365 (11): 1014-1024.
13. Poordad F, McCone J Jr, Bacon BR, et al,. SPRINT-2 Investigators. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364 (13): 1195-1206.
14. Bacon BR, Gordon SC, Lawitz E, et al,. HCV RESPOND-2 Investigators. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364 (13): 1207-1217.
15. Limaye AR, Draganov PV, Cabrera R,. Boceprevir for chronic HCV genotype 1 infection. N Engl J Med 2011; 365 (2): 176; author reply 177-8. No abstract available.
16. Centers for Disease Control and Prevention. Hepatitis C FAQs for Health Professionals. Available at: www.cdc.gov/hepatitis/HCV/HCVfaq.htm (accessed 6 January, 2011).
17. McGarry LJ, Pawar VS, Parekh HH, et al,. Economic Model of a Birth Cohort Screening Program for Hepatitis C Virus (HCV). Hepatology 2012; 55 (5): 1344-1355.
18. Rein DB, Smith BD, Wittenborn JS, et al,. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S primary care settings. Ann Intern Med 2012; 156 (4): 263-270.
19. Center for Disease Control and Prevention. Hepatitis C: proposed Expansion of Testing Recommendations, 2012. Available at: www.cdc.gov/nchhstp/ newsroom/docs/HCV-TestingFactSheetNoEmbargo508.pdf (accessed 1 August 2012)
20. Stepanova M, Kanwal F, El-Serag HB, Younossi ZM,. Insurance status and treatment candidacy of hepatitis c patients: analysis of population-based data from the United States. Hepatology 2011; 53 (3): 737-745.
21. Younossi ZM, Kallman J, Kincaid J,. The effects of HCV infection and management on health-related quality of life. Hepatology 2007; 45 (3): 806-816.
22. Dan A, Younossi ZM,. Long-term improvement in health-related quality of life after orthotopic liver transplantation. Liver Transpl 2008; 14 (10): 1404-1145.
23. Kowdely K, Lawitz E, et al,. GS-7977 + PEG/RBV in HCV Genotype 1: the ATOMIC Trial An End To Response-Guided Therapy. J of Hepatology 2011; 54 (Suppl. 1): S31.
24. Lalezari J, Lawitz E, Rodriguez-Torres M, et al,. Once daily Psi-7977 Plus Pegifn/Rbv In A Phase 2b Trial: rapid virologic suppression in treatment-naive patients With Hcv Gt2/Gt3. J Hepatol 2011; 54 (Suppl. 1): S28.
25. Zeuzem S, Asselah T, Angus P, et al,. Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection. Gastroenterology 2011; 141 (6): 2047-2055.
26. Shiffman M,. Interferon-Free Regimens: The Near Future, the Likely and the Not So Likely. Clin Liver Dis 2011; 15 (3): 665-675.
27. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Household Adult Data File. Public use data file documentation number 77560. Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
28. Anonymous. Available at: http://www.cdc.gov/nchs/nhanes.htm (accessed 24June 2012).
29. Anonymous. Available at: http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/ HEPC-F.htm (accessed 24 June 2012).
30. Anonymous. Available at: www.cdc.gov/nchs/nhanes/nhanes2007-2008/HCQ-E. htm (accessed 24 June 2012).
31. Nease DE Jr, Maloin JM,. Depression screening: a practical strategy. J Fam Pract 2003; 52 (2): 118-124.
32. Denniston MM, Klevens RM, McQuillan GM, Jiles RB,. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: national health and nutrition examination survey 2001-2008. Hepatology 2012; 55 (6): 1652-1661.